Equine IL-1ra/IL-1F3 ELISA Kit (NR-E10027)
search
  • Equine IL-1ra/IL-1F3 ELISA Kit (NR-E10027)

Equine IL-1ra/IL-1F3 ELISA Kit

Catalog # NR-E10027

Print

$944.50
Product Size: 1x96T
Quantity

For research use only. Not for diagnostic or therapeutic use, or for human or veterinary use. Sold only to research institutions and qualified laboratory professionals. Not for sale to individuals for personal use.

Assay Range

0.312-20 ng/ml

Sensitivity

0.1 ng/ml

Specificity

No cross-reaction with other related substances detected

Size

96T

Storage

Store at 2 - 8ºC. Keep reconstituted standard and detection Ab at -20 ºC

Assay Principle

Sandwich ELISA

Sample Volume

100 µL final volume, dilution factor varies on samples

Sample Type

Cell culture supernatants.

Detection Method

Chromogenic

 

 

Kit Components

 

 1. Recombinant EquineIL-1 ra/IL-1F3 standard: 2 vials

 2. One 96-well plate coated with Equine IL-1 ra/IL-1F3  Ab

 3. Sample diluent buffer: 12 mL - 1

 4. Detection antibody: 1 vial

 5. Streptavidin-HRP: 1 vial

 6. Antibody diluent buffer:12 mL x1  

 7. Streptavidin-HRP diluent buffer: 12 mL x1

 8. Chromogenic solution  A:  6 mlx1

 9. Chromogenic solution  B: 6 mlx1

10. Stop solution:  6 mL x1

11. Washing solution (20x):  25 mL x1

 

Background     

Interleukin-1 receptor antagonist (IL-1ra), also known as IL-1F3, ICIL-1RA, IL-1 inhibitor, is a member of the IL-1 family. Human IL-1ra is synthesized as a 177 aa precursor protein composed of a 25 aa signal sequence and a 152 aa mature region. Mature human IL-1ra is 77% and 82% aa identical to mouse and canine IL-1ra, respectively, and shows species cross-reactivity on mouse cells. It is reported that IL-1ra is expressed on diverse cells including monocytes, Sertoli cells, hepatocytes, adipocytes, synovial fibroblasts, mast cells, pancreatic β-cells, and intestinal epithelial cells.

IL-1 initiates a series of biological processes by binding to widely expressed IL-1 type I receptors (IL-1 RI). On endothelial cells (EC), IL-1 induces PGE2 and IL-6 release, generating fever, thrombocytosis, and hepatic acute phase protein production. In synovial joints, IL-1 induces chondrocyte NO production, leading to reduced collagen synthesis and chondrocyte apoptosis. IL-1 increases neutrophil counts, both in blood and tissue, and thus is able to promote a pro-inflammatory environment in multiple locations. IL-1ra blocks IL-1 action through competitive inhibition. Although IL-1ra fills the IL-1 binding site in IL-1 RI, it is unable to assist the formation of a signal-transducing IL-1 RI:IL-1 R Accessory protein (IL-1 R AcP) heterodimer complex. In other words, IL-1ra is a pure cytokine receptor antagonist that has no signal transduction-initiating activity.

New